AC
Acer Therapeutics
ACER·NASDAQNewton MAFounded 201315 employees
Micro CapbiotechPublicRare DiseaseMetabolic
Platform: ACER-001 UCD
Market Cap
$0.02B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ACER)
Loading ACER stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Terarapivir | ACE-1350 | Phase 1 | 1 | C5 | RB | ||
| ACE-6753 | ACE-6753 | Phase 2/3 | 2 | EZH2 | AsthmaPV |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)